$285 Million is the total value of Endurant Capital Management LP's 50 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 66.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HUM | Sell | HUMANA INC | $12,688,000 | +0.1% | 27,106 | -6.9% | 4.45% | +33.3% |
SPY | Sell | SPDR S&P 500 ETF TRput | $9,771,000 | -78.8% | 25,900 | -74.6% | 3.43% | -71.7% |
LH | Sell | LABORATORY CORP AMER HLDGS | $8,137,000 | -49.6% | 34,718 | -43.3% | 2.86% | -32.9% |
BIO | Sell | BIO RAD LABS INCcl a | $7,934,000 | -17.9% | 16,028 | -6.5% | 2.78% | +9.4% |
CNC | Sell | CENTENE CORP DEL | $5,779,000 | -68.5% | 68,305 | -68.7% | 2.03% | -58.1% |
MCK | Sell | MCKESSON CORP | $5,214,000 | -41.6% | 15,984 | -45.2% | 1.83% | -22.2% |
ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,101,000 | -30.3% | 1,824,065 | -15.6% | 1.09% | -7.2% |
OCUL | Sell | OCULAR THERAPEUTIX INC | $3,056,000 | -33.2% | 760,228 | -17.7% | 1.07% | -11.0% |
GLPG | Sell | GALAPAGOS NVspon adr | $2,869,000 | -11.7% | 51,410 | -1.9% | 1.01% | +17.5% |
INSM | Sell | INSMED INC | $2,802,000 | -27.9% | 142,071 | -14.0% | 0.98% | -3.9% |
THC | Sell | TENET HEALTHCARE CORP | $2,494,000 | -77.9% | 47,442 | -63.9% | 0.88% | -70.6% |
XBI | Sell | SPDR SER TRs&p biotech | $2,328,000 | -44.2% | 31,349 | -32.5% | 0.82% | -25.7% |
ALBO | Sell | ALBIREO PHARMA INC | $751,000 | -79.2% | 37,835 | -68.7% | 0.26% | -72.3% |
AXSM | Sell | AXSOME THERAPEUTICS INC | $584,000 | -85.9% | 15,246 | -84.8% | 0.20% | -81.2% |
PRAX | Sell | PRAXIS PRECISION MEDICINES I | $194,000 | -76.1% | 79,097 | -0.4% | 0.07% | -68.2% |
IMUX | Sell | IMMUNIC INC | $106,000 | -92.8% | 30,591 | -76.6% | 0.04% | -90.5% |
PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -243,795 | -100.0% | -0.08% | – |
Exit | DARIOHEALTH CORP | $0 | – | -73,779 | -100.0% | -0.11% | – | |
GOSS | Exit | GOSSAMER BIO INC | $0 | – | -68,710 | -100.0% | -0.16% | – |
CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -3,308 | -100.0% | -0.25% | – |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -59,474 | -100.0% | -0.26% | – |
NTRA | Exit | NATERA INC | $0 | – | -24,747 | -100.0% | -0.26% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -60,720 | -100.0% | -0.27% | – |
CDNA | Exit | CAREDX INC | $0 | – | -28,048 | -100.0% | -0.27% | – |
MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -314,238 | -100.0% | -0.29% | – |
DVA | Exit | DAVITA INCput | $0 | – | -10,000 | -100.0% | -0.30% | – |
RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -105,792 | -100.0% | -0.32% | – |
ICUI | Exit | ICU MED INC | $0 | – | -6,093 | -100.0% | -0.36% | – |
ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -4,480 | -100.0% | -0.37% | – |
VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -83,217 | -100.0% | -0.40% | – |
AFMD | Exit | AFFIMED N V | $0 | – | -354,492 | -100.0% | -0.41% | – |
ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -10,379 | -100.0% | -0.45% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -6,982 | -100.0% | -0.48% | – |
BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -15,400 | -100.0% | -0.48% | – |
TXG | Exit | 10X GENOMICS INC | $0 | – | -24,923 | -100.0% | -0.50% | – |
KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -15,342 | -100.0% | -0.51% | – |
TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -18,236 | -100.0% | -0.56% | – |
MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -1,765 | -100.0% | -0.64% | – |
PINC | Exit | PREMIER INCcl a | $0 | – | -75,632 | -100.0% | -0.71% | – |
IDXX | Exit | IDEXX LABS INC | $0 | – | -5,729 | -100.0% | -0.83% | – |
AHCO | Exit | ADAPTHEALTH CORP | $0 | – | -248,314 | -100.0% | -1.05% | – |
EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -65,653 | -100.0% | -1.23% | – |
ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -17,232 | -100.0% | -1.37% | – |
EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -44,561 | -100.0% | -1.38% | – |
SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -123,232 | -100.0% | -2.63% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -194,684 | -100.0% | -3.74% | – |
OFIX | Exit | ORTHOFIX MED INC | $0 | – | -434,803 | -100.0% | -3.74% | – |
AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -240,271 | -100.0% | -4.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
MCKESSON CORP | 27 | Q1 2023 | 4.4% |
CENCORA INC | 26 | Q3 2023 | 5.9% |
HOLOGIC INC | 24 | Q3 2023 | 7.5% |
JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
SC 13D/A | 2024-04-10 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-09-08 |
13F-HR | 2023-08-14 |
3/A | 2023-05-24 |
13F-HR | 2023-05-15 |
3 | 2023-05-15 |
SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.